The Chk1 Protein Kinase and the Cdc25C Regulatory Pathways Are Targets of the Anticancer Agent UCN-01
Paul R. Graves(NewYork–Presbyterian Brooklyn Methodist Hospital), Helen Piwnica‐Worms(Centre for Cancer Biology)
Cited by 541
Related Papers
Kinetics of regulated protein–protein interactions revealed with firefly luciferase complementation imaging in cells and living animals
|Proceedings of the National Academy of Sciences|2004|443
Contribution of p53 to Metastasis
|Cancer Discovery|2014|368
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
|Science Translational Medicine|2019|316
Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
|Journal of Clinical Investigation|2012|222